Medigen Vaccine Biologics Corporation (TPEX:6547)
Taiwan · Delayed Price · Currency is TWD 37.75
-0.05 (-0.13%)
Dec 31, 2025, 1:30 PM CST
Medigen Vaccine Biologics Market Cap
Medigen Vaccine Biologics has a market cap or net worth of 12.41 billion as of December 31, 2025. Its market cap has decreased by -0.13% in one year.
Market Cap
12.41B
Enterprise Value
11.04B
Revenue
594.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
37.75
Market Cap Chart
Since August 6, 2015, Medigen Vaccine Biologics's market cap has increased from 2.83B to 12.41B, an increase of 337.75%. That is a compound annual growth rate of 15.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 12.41B | 4.72% |
| Dec 31, 2024 | 11.85B | -48.55% |
| Dec 29, 2023 | 23.04B | 1.10% |
| Dec 30, 2022 | 22.78B | -64.20% |
| Dec 30, 2021 | 63.65B | 192.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 250.47B |
| PharmaEssentia | 179.19B |
| Lotus Pharmaceutical | 74.95B |
| Heron Neutron Medical | 70.34B |
| Bora Pharmaceuticals Co., LTD. | 61.64B |
| Lin BioScience | 32.06B |
| Lumosa Therapeutics | 31.92B |
| Center Laboratories | 29.26B |